TCL Archive New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years October 26, 2012
TCL Archive In Brief: NCI Scientist Accused Of Taking ‘Payoffs’ Forom Drug Firms; GM-CS Wins FDA Approval March 15, 1991
TCL Archive NIH Grant Funding to Use Percentiles Instead Of Priority Scores; Minimal Impact Seen By NCI January 22, 1988
TCL Archive In Breif: FDA Issues Uterine Cancer-Tamoxifin Warning; Fisher Declined Invitation To Speak At AACR April 15, 1994